Search details
1.
Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial.
Lancet
; 401(10373): 294-302, 2023 01 28.
Article
in English
| MEDLINE | ID: mdl-36709074
2.
Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B Cells.
J Immunol
; 201(12): 3804-3814, 2018 12 15.
Article
in English
| MEDLINE | ID: mdl-30413671
3.
Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes: A Randomized Clinical Trial.
JAMA
; 323(14): 1369-1377, 2020 04 14.
Article
in English
| MEDLINE | ID: mdl-32286643
4.
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials.
Lancet
; 391(10120): 552-562, 2018 02 10.
Article
in English
| MEDLINE | ID: mdl-29217376
5.
Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans.
J Virol
; 91(24)2017 12 15.
Article
in English
| MEDLINE | ID: mdl-28978707
6.
First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.
J Infect Dis
; 215(1): 95-104, 2017 Jan 01.
Article
in English
| MEDLINE | ID: mdl-28077588
7.
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.
Ann Intern Med
; 164(5): 313-22, 2016 Mar 01.
Article
in English
| MEDLINE | ID: mdl-26833336
8.
A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative Men.
J Infect Dis
; 214(9): 1341-1348, 2016 Nov 01.
Article
in English
| MEDLINE | ID: mdl-27521362
9.
Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene.
J Infect Dis
; 213(12): 1946-54, 2016 06 15.
Article
in English
| MEDLINE | ID: mdl-26908741
10.
Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1.
Mol Ther
; 22(2): 464-475, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24166483
11.
Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial.
Lancet Infect Dis
; 22(8): 1210-1220, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35568049
12.
A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).
J Infect Dis
; 201(4): 600-7, 2010 Feb 15.
Article
in English
| MEDLINE | ID: mdl-20078213
13.
Performance of International AIDS Vaccine Initiative African clinical research laboratories in standardised ELISpot and peripheral blood mononuclear cell processing in support of HIV vaccine clinical trials.
Afr J Lab Med
; 10(1): 1056, 2021.
Article
in English
| MEDLINE | ID: mdl-33833946
14.
Magnitude, breadth, and functional profile of T-cell responses during human immunodeficiency virus primary infection with B and BF viral variants.
J Virol
; 82(6): 2853-66, 2008 Mar.
Article
in English
| MEDLINE | ID: mdl-18184702
15.
Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial.
Lancet HIV
; 6(4): e230-e239, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30885692
16.
A high viral burden predicts the loss of CD8 T-cell responses specific for subdominant gag epitopes during chronic human immunodeficiency virus infection.
J Virol
; 81(24): 13809-15, 2007 Dec.
Article
in English
| MEDLINE | ID: mdl-17898052
17.
Varicella zoster virus--specific immune response after treatment with sodium stibogluconate for cutaneous leishmaniasis.
Am J Trop Med Hyg
; 78(3): 402-5, 2008 Mar.
Article
in English
| MEDLINE | ID: mdl-18337334
18.
In a mixed subtype epidemic, the HIV-1 Gag-specific T-cell response is biased towards the infecting subtype.
AIDS
; 21(2): 135-43, 2007 Jan 11.
Article
in English
| MEDLINE | ID: mdl-17197803
19.
Cryopreservation-related loss of antigen-specific IFNγ producing CD4+ T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudy.
Vaccine
; 35(15): 1898-1906, 2017 04 04.
Article
in English
| MEDLINE | ID: mdl-28285985
20.
CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.
BMC Immunol
; 7: 8, 2006 Apr 18.
Article
in English
| MEDLINE | ID: mdl-16620386